Cost-effectiveness analysis of hepatitis C virus (HCV) point-of-care assay for HCV screening.

Vanessa KooFeng TianWilliam W L Wong

Published in: Liver international : official journal of the International Association for the Study of the Liver (2021)

The implementation of HCV point-of-care screening in Canada is likely to be cost-saving for IDUs. Early detection and treatment of undiagnosed individuals can prolong people's life span and save healthcare costs associated with HCV-related complications.

Keyphrases

hepatitis c virus
human immunodeficiency virus
healthcare
primary care
high throughput
quality improvement
hiv infected
antiretroviral therapy
health information
replacement therapy